![]() Press Release Distribution |
Nevada Biotech News (United States)+ XML/RSS203 views, By Sierra Sciences Longevity experts to speak at a presentation in the Bay Area. Dr. Bill Andrews, leading telomerase expert and longevity researcher, to appear with Dr. Michael Colgan and Dr. Paul Anderson at “A Day with the Doctors: Live Healthy, Live Long!” 63 views, By Pak Smithsoner SYNNEX Corporation (SNX) reported financial results for the fiscal second quarter ended May 31, 2011. Highlights include: - Revenue from continuing operations was $2.46 billion, an increase of 22.5% over the prior fiscal year quarter. 70 views, By Pak Smithsoner SIGA to Sell 1.7 Million Courses of ST-246(R) to National Stockpile Under Modified BARDA Contract 588 views, By PR Authority Yvette Kendall is considered a New World Inventor and has graced us with such products like The Scalers New Fitness Shoes, Cleencups, The Bookman, Diabandix and a countless number of other idea concepts that will make our lives better. 916 views, By Nevada State College Offering students a training advantage for jobs at top biotech companies, this state-of-the-art workshop will be the first and only of its kind available to college students in the United States, and it is happening at Nevada State College. 514 views, By Nina Online After 15 years of research, Amega Global has unlocked the secret to self-healing. By applying the principles of Quantum Physics and Quantum Mechanics, they discovered a way to “capture” Zero Point Energy to promote healing and overall well being. 230 views, By Patrick Bergin Business and scientific leaders in the biopharmaceutical markets now have a new resource to help get news out to the industry and the public. 319 views, By iDentalfy Las Vegas, NV April 30, 2010. – 3MPlants Inc. is pleased to announce that Phase 1 Clinical Trial of its virtual diagnosing and artificial intelligence system has been completed. Biotechnology Stock News: Natural Anti Inflammatory Drug Products Developer Makes Major Acquisitions 1554 views, By Princeton Research Biotechnology developer of natural anti inflammatory drugs, Metabolic Research Inc. (Stock Symbol: MTBR), acquires biotechnology products marketing company and the proprietary technologies |
|